“The Food and Drug Administration has approved two new antibiotics for the treatment of gonorrhea, giving health care providers powerful new weapons against a sexually transmitted disease that has become increasingly hard to treat.

Neisseria gonorrhoeae, the bacterium that causes gonorrhea, is a wily nemesis that has outsmarted every previous antibiotic deployed against it, including the sole therapy that remains effective.

On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a clinical trial had found that a single oral dose of the drug was safe and effective against gonorrhea. The disease infects more than 80 million people each year and can have serious health implications.

A day earlier, the agency approved the expanded use of another new antibiotic to treat gonorrhea. The drug, gepotidacin, developed by GSK, had previously been approved to treat urinary tract infections in women.

Infectious disease experts were buoyed by the news.”

From New York Times.